Yew Bio-Pharm Group, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 7,440 6,728 5,961
Cost of Revenue 2,407 1,279 1,126
Gross Profit 5,032 5,448 4,835
Operating Expenses
Research and Development - - -
Sales, General and Admin. 1,135 3,244 788
Non-Recurring Items - - -
Other - - -
Operating Income 3,898 2,205 4,047
Income From Continuing Operations
Add'l Income/Expense Items 2 2 (6)
Earnings Before Interest and Tax 3,900 2,206 4,040
Interest Expense - - -
Earnings Before Tax 3,900 2,206 4,040
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations 3,900 2,206 4,040
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income 3,900 2,206 4,040
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders 3,900 2,206 4,040